[ad_1]
HTG Molecular Diagnostics HTGM reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
HTG Molecular Diagnostics beat estimated earnings by 10.0%, reporting an EPS of $-0.54 versus an estimate of $-0.6.
Revenue was down $582 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1 which was followed by a 0.34% increase in the share price the next day.
Here’s a look at HTG Molecular Diagnostics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.71 | -0.59 | -0.66 | -0.77 |
| EPS Actual | -0.81 | -0.69 | -0.60 | -0.65 |
| Revenue Estimate | 2.15M | 2.97M | 2.65M | 2.13M |
| Revenue Actual | 1.18M | 2.88M | 2.52M | 2.07M |
To track all earnings releases for HTG Molecular Diagnostics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.